Add BrightSurf on Google Email

American Thoracic Society Journal news tips for May 2004 (second issue)

A recent study suggests that surgery provides a favorable outcome for long-term multidrug-resistant tuberculosis patients. The surgeons at the National Jewish Medical and Research Center have extensive experience in treating mycobacterial lung disease, making them uniquely qualified to assess individual patient risk/benefit balances.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 18, 2004

Early promise for new antimalarial drug

A new antibiotic, fosmidomycin, has been shown to be effective against the Plasmodium falciparum parasite, with rapid parasite elimination and fever reduction. Cure rates after two weeks were 89%, 88%, and 60% for treatment durations of 5, 4, and 3 days, respectively.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 12, 2002

Experts announce global antimicrobial resistance initiative - World preview of the Global White Paper on bacterial resistance in respiratory tract infections - a call for concerted international action

A global white paper on bacterial resistance in respiratory tract infections calls for concerted international action to tackle the growing threat of antibiotic-resistant bacteria. The initiative aims to implement robust surveillance, education, and patient involvement to control resistance.

How bacteria harden their "armor"

Scientists at Duke University have discovered a new enzyme that attaches aminoarabinose to the outer coat of gram-negative bacteria, reducing the ability of positively charged antibiotics to attach and kill them. This discovery offers a potential approach to overcoming antibiotic resistance.

SourceDuke University·JournalJournal of Biological Chemistry·DateSep 18, 2001

Early case of resistance to new antibiotic

A new case of resistance to the antibiotic linezolid has been reported in a patient with MRSA infection, highlighting the need for clinical laboratories to perform susceptibility tests. The finding is rare and has occurred after limited use of the drug, emphasizing the importance of monitoring its effectiveness.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 19, 2001

Chemists take new approach to fighting resistance

Researchers at Wayne State University have designed two novel antibiotics to combat antibiotic resistance. The 'self-destructive' antibiotic breaks down in the presence of light, while the 'self-regenerating' antibiotic remains effective against resistant bacteria by releasing its active form after encountering resistance enzymes.

SourceAmerican Chemical Society·JournalJournal of Medicinal Chemistry·DateDec 19, 1999